{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-002881","form_type":"8-K/A","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2024-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.444650+00:00","generated_at":"2026-06-07T00:32:11.043658+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Silo Pharma extends stock repurchase program of up to $1M through March 31, 2024","bullets":["Board approved extension of stock repurchase program authorizing up to $1M in common stock purchases until March 31, 2024.","As of Dec 31, 2023, company repurchased 264,196 shares for total cost of $487,016 under the program.","Extension approved on January 9, 2024; original program was previously announced but not detailed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-002881","json":"https://secwatch.observer/filing/0001213900-24-002881.json","markdown":"https://secwatch.observer/filing/0001213900-24-002881.md","text":"https://secwatch.observer/filing/0001213900-24-002881.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024002881/0001213900-24-002881-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024002881/ea191517-8k_silo.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:32:11.043658+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}